CANDELARIO SOSA: Open Payments
NPI 1124026661 · SAN JUAN, PR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$507 in 20 payments from 5 companies in 2025. Trend: 2023 $524 · 2024 $996 · 2025 $507
Food & beverage: $507
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 8 | $202 |
| ViiV Healthcare Company | 5 | $127 |
| Johnson and Johnson International | 3 | $73 |
| Janssen Pharmaceuticals, Inc | 2 | $56 |
| Merck Sharp & Dohme LLC | 2 | $49 |
Products named: CABENUVA, Biktarvy, DOVATO, PIFELTRO, CARTO 3, SYMTUZA, INVEGA SUSTENNA, QDOT MICRO.
Industry payments across PR — which companies pay providers there.
